Literature DB >> 25832438

Plasma jet's shielding gas impact on bacterial inactivation.

Helena Jablonowski1, Mareike A Ch Hänsch2, Mario Dünnbier1, Kristian Wende1, Malte U Hammer1, Klaus-Dieter Weltmann2, Stephan Reuter1, Thomas von Woedtke2.   

Abstract

One of the most desired aims in plasma medicine is to inactivate prokaryotic cells and leave eukaryotic cells unharmed or even stimulate proliferation to promote wound healing. The method of choice is to precisely control the plasma component composition. Here the authors investigate the inactivation of bacteria (Escherichia coli) by a plasma jet treatment. The reactive species composition created by the plasma in liquids is tuned by the use of a shielding gas device to achieve a reactive nitrogen species dominated condition or a reactive oxygen species dominated condition. A strong correlation between composition of the reactive components and the inactivation of the bacteria is observed. The authors compare the results to earlier investigations on eukaryotic cells and show that it is possible to find a plasma composition where bacterial inactivation is strongest and adverse effects on eukaryotic cells are minimized.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25832438     DOI: 10.1116/1.4916533

Source DB:  PubMed          Journal:  Biointerphases        ISSN: 1559-4106            Impact factor:   2.456


  10 in total

1.  Role of Ambient Gas Composition on Cold Physical Plasma-Elicited Cell Signaling in Keratinocytes.

Authors:  Anke Schmidt; Sander Bekeschus; Helena Jablonowski; Annemarie Barton; Klaus-Dieter Weltmann; Kristian Wende
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

2.  Atmospheric Pressure Pulsed Plasma Induces Cell Death in Photosynthetic Organs via Intracellularly Generated ROS.

Authors:  You-Bin Seol; Jaewook Kim; Se-Hong Park; Hong Young Chang
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

3.  Quantification of the ozone and singlet delta oxygen produced in gas and liquid phases by a non-thermal atmospheric plasma with relevance for medical treatment.

Authors:  Helena Jablonowski; Joao Santos Sousa; Klaus-Dieter Weltmann; Kristian Wende; Stephan Reuter
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

4.  Nitrosylation vs. oxidation - How to modulate cold physical plasmas for biological applications.

Authors:  Jan-Wilm Lackmann; Giuliana Bruno; Helena Jablonowski; Friederike Kogelheide; Björn Offerhaus; Julian Held; Volker Schulz-von der Gathen; Katharina Stapelmann; Thomas von Woedtke; Kristian Wende
Journal:  PLoS One       Date:  2019-05-08       Impact factor: 3.240

Review 5.  Possible Synergies of Nanomaterial-Assisted Tissue Regeneration in Plasma Medicine: Mechanisms and Safety Concerns.

Authors:  Priyanka Shaw; Patrick Vanraes; Naresh Kumar; Annemie Bogaerts
Journal:  Nanomaterials (Basel)       Date:  2022-09-28       Impact factor: 5.719

6.  Spatial Dependence of DNA Damage in Bacteria due to Low-Temperature Plasma Application as Assessed at the Single Cell Level.

Authors:  Angela Privat-Maldonado; Deborah O'Connell; Emma Welch; Roddy Vann; Marjan W van der Woude
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

7.  Improved performance of a barrier-discharge plasma jet biased by a direct-current voltage.

Authors:  Xuechen Li; Yaru Li; Panpan Zhang; Pengying Jia; Lifang Dong
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

8.  Non-Thermal Plasma in Contact with Water: The Origin of Species.

Authors:  Yury Gorbanev; Deborah O'Connell; Victor Chechik
Journal:  Chemistry       Date:  2016-02-02       Impact factor: 5.236

Review 9.  Redox for Repair: Cold Physical Plasmas and Nrf2 Signaling Promoting Wound Healing.

Authors:  Anke Schmidt; Sander Bekeschus
Journal:  Antioxidants (Basel)       Date:  2018-10-19

10.  Novel method for reduction of virus load in blood plasma by sonication.

Authors:  D Pförringer; K F Braun; H Mühlhofer; J Schneider; A Stemberger; E Seifried; E Pohlscheidt; M Seidel; G Edenharter; D Duscher; R Burgkart; A Obermeier
Journal:  Eur J Med Res       Date:  2020-04-07       Impact factor: 2.175

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.